Drug Innovation Will Accelerate Chinese Industry Shakeout
This article was originally published in PharmAsia News
Executive Summary
China's pharmaceutical manufacturing and innovation project, which seeks to boost the local industry's innovative capability, will support research and development and market expansion of key drugs. Within five years, the government hopes to see products with annual sales of 10 billion yuan as well as grow local enterprises that can compete with international pharmaceutical giants. Analysts believe that under the initiative, strong players with innovative strategies will thrive while weaker ones will be acquired by big enterprises or get eliminated. Generic drug and traditional Chinese medicine innovations are some possible approaches to creating new drugs without patent infringement, while talent, land, taxation laws, and supporting policies, such as a shorter drug approval process will help spur local innovation. (Click here for more)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.